Clinical Trial Update: Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating carisbamate as adjunctive treatment for seizures in Lennox-Gastaut syndrome; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Lennox-gastaut Syndrome

Drugs mentioned

• carisbamate (carisbamate)

Snippet

Sponsor: SK Life Science, Inc. | Conditions: Seizures, Lennox Gastaut Syndrome | Phase 3 | Status: RECRUITING